Purdue Pharma, the maker of narcotic pain reliever OxyContin that's accused of contributing to opioid addiction related to 700,000 overdose deaths, filed for bankruptcy court protection as part of a proposed $10 billion settlement that could affect the financing and occupancy of its headquarters and a manufacturing plant.
OxyContin Maker's Legal Settlement Raises Questions Over Its Real Estate
Purdue Pharma to Relinquish Control on Leases as Part of Chapter 11 Reorganization
CoStar News
September 16, 2019 | 8:24 P.M.
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- One Stamford Forum
201 Tresser Blvd, Stamford, CT
- Companies